|12 Months Ended|
Dec. 31, 2016
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of trade accounts receivable. The Company performs ongoing credit evaluations of its customers and generally does not require collateral related to its trade accounts receivable. At December 31, 2016, accounts receivable from one customer comprised 100% of the company’s total accounts receivable-trade. Revenues from one customer approximated 87% of total revenues for 2016. At December 31, 2015, accounts receivable from two customers comprised approximately 100% of the Company’s total accounts receivable-trade. Revenues from two customers approximated 71% of total revenues for 2015.
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
Reference 1: http://www.xbrl.org/2003/role/presentationRef